Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRho-dependent protein serine/threonine kinase activity

ROCK2 ROCK1

2.64e-0521032GO:0072518
GeneOntologyMolecularFunctionATP-dependent activity

ABCC1 DNAH3 MYO6 IDE ATP8B2 ABCA9 ACSL4 IQCA1L ACSBG2 ACSM6 TOP2A TOP2B

7.66e-0561410312GO:0140657
GeneOntologyMolecularFunctiontranslation elongation factor activity

EEF1A1 EEF1A1P5 EEF1A2

1.43e-04201033GO:0003746
GeneOntologyMolecularFunctionDNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity

TOP2A TOP2B

1.57e-0441032GO:0003918
GeneOntologyMolecularFunctiontau-protein kinase activity

ROCK2 DYRK1A ROCK1

1.91e-04221033GO:0050321
GeneOntologyMolecularFunctionfatty acid ligase activity

ACSL4 ACSBG2 ACSM6

3.18e-04261033GO:0015645
GeneOntologyMolecularFunctionCoA-ligase activity

ACSL4 ACSBG2 ACSM6

3.56e-04271033GO:0016405
GeneOntologyMolecularFunctionacid-thiol ligase activity

ACSL4 ACSBG2 ACSM6

5.39e-04311033GO:0016878
GeneOntologyMolecularFunctionDNA topoisomerase activity

TOP2A TOP2B

7.23e-0481032GO:0003916
GeneOntologyCellularComponentruffle

RASA1 MYO6 IFIT5 ARFIP2 EEF1A1 ROCK1 FGD5

7.26e-052061037GO:0001726
GeneOntologyCellularComponenteukaryotic translation elongation factor 1 complex

EEF1A1 EEF1A2

1.43e-0441032GO:0005853
Domain-

TOP2A TOP2B

3.01e-05210323.40.50.670
DomainDTHCT

TOP2A TOP2B

3.01e-0521032IPR012542
DomainDNA_gyraseB

TOP2A TOP2B

3.01e-0521032PF00204
DomainRho_Binding

ROCK2 ROCK1

3.01e-0521032PF08912
Domain-

TOP2A TOP2B

3.01e-05210323.90.199.10
DomainTopoIIA_CS

TOP2A TOP2B

3.01e-0521032IPR018522
DomainRho-bd_dom

ROCK2 ROCK1

3.01e-0521032IPR015008
DomainTransl_elong_EF1A_euk/arc

EEF1A1 EEF1A2

3.01e-0521032IPR004539
DomainTopo_IIA

TOP2A TOP2B

3.01e-0521032IPR001241
DomainDNA_topoisoIV

TOP2A TOP2B

3.01e-0521032PF00521
DomainTopo_IIA_A/C_ab

TOP2A TOP2B

3.01e-0521032IPR013758
DomainTopo_IIA_A_a

TOP2A TOP2B

3.01e-0521032IPR013757
DomainTopo_IIA_cen_dom

TOP2A TOP2B

3.01e-0521032IPR013759
DomainTOP4c

TOP2A TOP2B

3.01e-0521032SM00434
DomainTOP2c

TOP2A TOP2B

3.01e-0521032SM00433
DomainTopo_IIA-like_dom

TOP2A TOP2B

3.01e-0521032IPR013760
DomainTopo_IIA_bsu_dom2

TOP2A TOP2B

3.01e-0521032IPR013506
DomainDTHCT

TOP2A TOP2B

3.01e-0521032PF08070
Domain-

TOP2A TOP2B

3.01e-05210321.10.268.10
DomainROCK1/ROCK2

ROCK2 ROCK1

3.01e-0521032IPR020684
DomainTOPRIM_C

TOP2A TOP2B

3.01e-0521032IPR031660
DomainTOPRIM_C

TOP2A TOP2B

3.01e-0521032PF16898
DomainTopo_IIA_A/C

TOP2A TOP2B

3.01e-0521032IPR002205
DomainTOPOISOMERASE_II

TOP2A TOP2B

3.01e-0521032PS00177
DomainPH

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

3.95e-052291038PF00169
DomainCASH

FBXO10 SHCBP1L

9.00e-0531032SM00722
DomainArg_repress_C-like

TOP2A TOP2B

9.00e-0531032IPR024946
Domain-

TOP2A TOP2B

9.00e-05310323.30.1360.40
DomainCarb-bd_sugar_hydrolysis-dom

FBXO10 SHCBP1L

9.00e-0531032IPR006633
DomainPH

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

1.53e-042781038SM00233
DomainPH_DOMAIN

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

1.57e-042791038PS50003
DomainPH_domain

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

1.60e-042801038IPR001849
DomainNebulin

NRAP NEB

1.79e-0441032PF00880
DomainToprim

TOP2A TOP2B

1.79e-0441032PF01751
DomainNEBULIN

NRAP NEB

1.79e-0441032PS51216
DomainNEBU

NRAP NEB

1.79e-0441032SM00227
DomainNebulin

NRAP NEB

1.79e-0441032IPR013998
DomainToprim_domain

TOP2A TOP2B

1.79e-0441032IPR006171
DomainNebulin_repeat

NRAP NEB

1.79e-0441032IPR000900
DomainTOPRIM

TOP2A TOP2B

1.79e-0441032PS50880
DomainAH_dom

ARFIP2 ICA1L

2.98e-0451032IPR010504
DomainArfaptin

ARFIP2 ICA1L

2.98e-0451032SM01015
DomainArfaptin

ARFIP2 ICA1L

2.98e-0451032PF06456
DomainAH

ARFIP2 ICA1L

2.98e-0451032PS50870
DomainPectin_lyas_fold

FBXO10 SHCBP1L

4.45e-0461032IPR012334
DomainFAD-bd

MICAL2 MICAL3

4.45e-0461032IPR002938
DomainPbH1

FBXO10 SHCBP1L

4.45e-0461032SM00710
Domain-

FBXO10 SHCBP1L

4.45e-04610322.160.20.10
DomainFAD_binding_3

MICAL2 MICAL3

4.45e-0461032PF01494
DomainPbH1

FBXO10 SHCBP1L

4.45e-0461032IPR006626
DomainRICIN

GALNT11 GALNT5 LY75

4.83e-04281033SM00458
DomainAMP_BINDING

ACSL4 ACSBG2 ACSM6

4.83e-04281033PS00455
DomainRICIN_B_LECTIN

GALNT11 GALNT5 LY75

4.83e-04281033PS50231
DomainRicin_B_lectin

GALNT11 GALNT5 LY75

5.93e-04301033IPR000772
DomainAMP-binding

ACSL4 ACSBG2 ACSM6

5.93e-04301033PF00501
DomainAMP-dep_Synth/Lig

ACSL4 ACSBG2 ACSM6

5.93e-04301033IPR000873
DomainIRF-3

IRF4 IRF9

6.21e-0471032PF10401
DomainIRF-3

IRF4 IRF9

6.21e-0471032SM01243
DomainInterferon_reg_factor-3

IRF4 IRF9

6.21e-0471032IPR019471
DomainTransl_elong_EFTu/EF1A_C

EEF1A1 EEF1A2

8.25e-0481032IPR004160
DomainPectin_lyase_fold/virulence

FBXO10 SHCBP1L

8.25e-0481032IPR011050
DomainHR1

ROCK2 ROCK1

8.25e-0481032PF02185
DomainGTP_EFTU_D3

EEF1A1 EEF1A2

8.25e-0481032PF03143
DomainIRF

IRF4 IRF9

1.06e-0391032SM00348
DomainIRF

IRF4 IRF9

1.06e-0391032PF00605
DomainInterferon_reg_fac_CS

IRF4 IRF9

1.06e-0391032IPR019817
DomainInterferon_reg_fact_DNA-bd_dom

IRF4 IRF9

1.06e-0391032IPR001346
DomainG_TR_CS

EEF1A1 EEF1A2

1.06e-0391032IPR031157
DomainIRF_1

IRF4 IRF9

1.06e-0391032PS00601
DomainIRF_2

IRF4 IRF9

1.06e-0391032PS51507
DomainTransl_elong_EF1A/Init_IF2_C

EEF1A1 EEF1A2

1.32e-03101032IPR009001
Domain-

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

1.45e-0339110382.30.29.30
DomainG_TR_1

EEF1A1 EEF1A2

2.26e-03131032PS00301
DomainPH_dom-like

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

2.47e-034261038IPR011993
DomainFN_type2_col-bd

MMP2 LY75

2.62e-03141032IPR000562
DomainFN2_2

MMP2 LY75

2.62e-03141032PS51092
DomainFN2_1

MMP2 LY75

2.62e-03141032PS00023
Domainfn2

MMP2 LY75

2.62e-03141032PF00040
DomainFN2

MMP2 LY75

2.62e-03141032SM00059
DomainSMAD_dom-like

IRF4 IRF9

3.44e-03161032IPR017855
Domain-

IRF4 IRF9

3.44e-031610322.60.200.10
DomainEFTu-like_2

EEF1A1 EEF1A2

4.35e-03181032IPR004161
DomainHATPase_c

TOP2A TOP2B

4.35e-03181032SM00387
DomainGTP_EFTU_D2

EEF1A1 EEF1A2

4.35e-03181032PF03144
DomainG_TR_2

EEF1A1 EEF1A2

4.35e-03181032PS51722
DomainTF_GTP-bd_dom

EEF1A1 EEF1A2

4.84e-03191032IPR000795
DomainHATPase_c

TOP2A TOP2B

4.84e-03191032PF02518
DomainZF_DAG_PE_1

ROCK2 ROCK1 VAV1

5.32e-03641033PS00479
DomainZF_DAG_PE_2

ROCK2 ROCK1 VAV1

5.32e-03641033PS50081
Domain-

TOP2A TOP2B

5.36e-032010323.30.565.10
PathwayPID_SYNDECAN_2_PATHWAY

RASA1 ITGA2 CASK MMP2

4.41e-0533854M240
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

ROCK2 RPL27 MYO6 PDHB RAPGEF4 HNRNPM DYRK1A POR LARP1 OAT ITGA2 HNRNPD MYEF2 EEF1A1 EEF1A2 CASK MLXIPL MICAL2 XRN1 MICAL3 EXOC1 TRAPPC9

3.14e-1014311062237142655
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MCPH1 RASA1 MYO6 LARP1 IDE ITPK1 EEF1A2 CASK SMG7 SH3PXD2A MICAL2 GALNT11 TGFBRAP1 SGSM2 UCKL1 ANKRD11 MICAL3 FBXO21 ICA1L TRAPPC9

2.18e-0814891062028611215
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

ROCK2 RPL27 RAPH1 PDHB DZIP1L HNRNPM LARP1 IFIT5 NEB HNRNPD EEF1A1 EEF1A2 PHEX ACSL4 SH3PXD2A AVIL XRN1 TOP2A TOP2B

6.97e-0814421061935575683
Pubmed

Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).

ROCK2 ROCK1 MMP2

1.10e-074106331026254
Pubmed

Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice.

ROCK2 EEF1A1 ROCK1

1.10e-074106329353861
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

RPL27 TBRG4 MYO6 PDHB POLE TRPC1 HNRNPM POR LARP1 OAT IDE HNRNPD EEF1A1 TXNDC5 FGD5 GALNT5 TOP2A TOP2B

3.00e-0714251061830948266
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RPL27 RAPH1 KLHDC2 DYRK1A LARP1 MLXIP EEF1A1 EEF1A2 MLXIPL PIK3C2A SH3PXD2A XRN1 ANKRD11 TRAPPC9

3.76e-078611061436931259
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

RPL27 MYO6 PDHB POLE HNRNPM NCAPG2 HNRNPD MYEF2 ACSL4 PIK3C2A MICAL2 LTN1 XRN1 CBX1 EXOC1 TOP2A TOP2B

7.17e-0713531061729467282
Pubmed

EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.

RPL27 DNAH3 PDHB HNRNPM PLEKHS1 OAT HNRNPD MYEF2 EEF1A1 TXNDC5 SH3PXD2A CBX1 TOP2A

1.06e-068031061336517590
Pubmed

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.

DZIP1L EEF1A1 EEF1A1P5 EEF1A2 GLCE ACSBG2

1.57e-06116106630652415
Pubmed

Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.

RASA1 NEB PHEX VAV1

1.58e-0628106418067320
Pubmed

CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.

RPL27 MYO6 PDHB HNRNPM OAT HNRNPD EEF1A1 EEF1A2

3.00e-06288106831501420
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

ROCK2 RAPH1 LARP1 HNRNPD MYEF2 EEF1A1 EEF1A2 CASK XRN1 TOP2A

3.09e-064981061036634849
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

TBRG4 GOLGA6L2 MYO6 POLE IDE NEB MYEF2 ACSL4 TXNDC5 BUD31 FGD5

4.18e-066381061131182584
Pubmed

Proteomic analysis of the mitochondrial glucocorticoid receptor interacting proteins reveals pyruvate dehydrogenase and mitochondrial 60 kDa heat shock protein as potent binding partners.

PDHB POR HNRNPD EEF1A1P5 ACSL4

5.75e-0683106535124280
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

ROCK2 RPL27 TBRG4 HNRNPM LARP1 IFIT5 HNRNPD MYEF2 SCAF4 EEF1A1 XRN1 TOP2A

6.73e-068071061222681889
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

RPL27 PDHB HNRNPM LARP1 MLXIP HNRNPD EEF1A1 EEF1A2 CASK MLXIPL EXOC1 MMP2

6.90e-068091061232129710
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

RPL27 HNRNPM LARP1 HNRNPD SCAF4 EEF1A1 EEF1A1P5 EEF1A2 BUD31 ANKRD11 CBX1 TOP2A TOP2B

6.95e-069541061336373674
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

ABCC1 RPL27 GALC TBRG4 PDHB HNRNPM DYRK1A POR OAT ARFIP2 EEF1A1 ACSL4 TXNDC5 GLCE MMP2 TRAPPC9

8.28e-0614511061630550785
Pubmed

DNA topoisomerase II is dispensable for oocyte meiotic resumption but is essential for meiotic chromosome condensation and separation in mice.

TOP2A TOP2B

9.20e-062106224048577
Pubmed

ROCK 1 and 2 affect the spatial architecture of 3D spheroids derived from human corneal stromal fibroblasts in different manners.

ROCK2 ROCK1

9.20e-062106235523828
Pubmed

Inhibition of Rho kinase protects against colitis in mice by attenuating intestinal epithelial barrier dysfunction via MLC and the NF-κB pathway.

ROCK2 ROCK1

9.20e-062106229115372
Pubmed

Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma.

ROCK2 ROCK1

9.20e-062106224617500
Pubmed

[Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells].

ROCK2 ROCK1

9.20e-062106225916120
Pubmed

Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.

TOP2A TOP2B

9.20e-062106219222228
Pubmed

Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells.

TOP2A TOP2B

9.20e-06210622555055
Pubmed

ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.

ROCK2 ROCK1

9.20e-062106226468018
Pubmed

Characterization of cDNA encoding the mouse DNA topoisomerase II that can complement the budding yeast top2 mutation.

TOP2A TOP2B

9.20e-06210621331984
Pubmed

ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape.

ROCK2 ROCK1

9.20e-062106222462535
Pubmed

Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction.

ROCK2 ROCK1

9.20e-062106230165352
Pubmed

The Role of ROCK in Platelet-Monocyte Collaborative Induction of Thromboinflammation during Acute Coronary Syndrome.

ROCK2 ROCK1

9.20e-062106232877952
Pubmed

Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.

TOP2A TOP2B

9.20e-062106231106979
Pubmed

A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.

TOP2A TOP2B

9.20e-062106216091284
Pubmed

Toll-like receptor signaling in macrophages is regulated by extracellular substrate stiffness and Rho-associated coiled-coil kinase (ROCK1/2).

ROCK2 ROCK1

9.20e-062106229800294
Pubmed

Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

ROCK2 ROCK1

9.20e-062106218668558
Pubmed

ROCK1 and ROCK2 Are Down-regulated in Aggressive and Advanced Skin Melanomas - A Clinicopathological Perspective.

ROCK2 ROCK1

9.20e-062106232234882
Pubmed

Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.

ROCK2 ROCK1

9.20e-062106215096457
Pubmed

HMEC-1 adopt the mixed amoeboid-mesenchymal migration type during EndMT.

ROCK1 MMP2

9.20e-062106228487031
Pubmed

ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression.

ROCK2 ROCK1

9.20e-062106222934846
Pubmed

Functional role of Rho-kinase in ameloblast differentiation.

ROCK2 ROCK1

9.20e-062106221792909
Pubmed

Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.

ROCK2 ROCK1

9.20e-062106220803696
Pubmed

Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.

ROCK2 ROCK1

9.20e-062106226481340
Pubmed

eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency.

EEF1A1 EEF1A2

9.20e-062106230782564
Pubmed

Inhibition of ROCK activity allows InlF-mediated invasion and increased virulence of Listeria monocytogenes.

ROCK2 ROCK1

9.20e-062106218331468
Pubmed

The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis.

ROCK2 ROCK1

9.20e-062106229211497
Pubmed

The connection between the cardiac glycoside-induced senescent cell morphology and Rho/Rho kinase pathway.

ROCK2 ROCK1

9.20e-062106230369081
Pubmed

Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.

ROCK2 ROCK1

9.20e-062106223328676
Pubmed

The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.

ROCK2 ROCK1

9.20e-062106218695890
Pubmed

Mining topoisomerase isoforms in gastric cancer.

TOP2A TOP2B

9.20e-062106232535049
Pubmed

Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development.

TOP2A TOP2B

9.20e-06210621380833
Pubmed

Opposing signaling of ROCK1 and ROCK2 determines the switching of substrate specificity and the mode of migration of glioblastoma cells.

ROCK2 ROCK1

9.20e-062106224170433
Pubmed

Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation.

ROCK2 ROCK1

9.20e-062106212508221
Pubmed

Microcephalin/MCPH1 associates with the Condensin II complex to function in homologous recombination repair.

MCPH1 NCAPG2

9.20e-062106218718915
Pubmed

Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.

ROCK2 ROCK1

9.20e-062106218695640
Pubmed

Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase.

ROCK2 ROCK1

9.20e-062106215044207
Pubmed

Differential regulation of adhesion complex turnover by ROCK1 and ROCK2.

ROCK2 ROCK1

9.20e-062106222348083
Pubmed

MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells.

MLXIP MLXIPL

9.20e-062106229282201
Pubmed

Rho-associated kinase is a therapeutic target in neuroblastoma.

ROCK2 ROCK1

9.20e-062106228739902
Pubmed

Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription.

TOP2A TOP2B

9.20e-062106223399433
Pubmed

Common variants of ROCKs and the risk of hypertension, and stroke: Two case-control studies and a follow-up study in Chinese Han population.

ROCK2 ROCK1

9.20e-062106229246448
Pubmed

Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction.

ROCK2 ROCK1

9.20e-062106228679962
Pubmed

Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells.

TOP2A TOP2B

9.20e-062106215044480
Pubmed

C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

TOP2A TOP2B

9.20e-062106217526531
Pubmed

Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation.

ROCK2 ROCK1

9.20e-062106217167780
Pubmed

Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates.

ROCK2 ROCK1

9.20e-062106227269648
Pubmed

Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase.

ROCK2 ROCK1

9.20e-062106224289040
Pubmed

Analysis of the Expression and Subcellular Distribution of eEF1A1 and eEF1A2 mRNAs during Neurodevelopment.

EEF1A1 EEF1A2

9.20e-062106235741005
Pubmed

Rho kinase in the regulation of cell death and survival.

ROCK2 ROCK1

9.20e-062106217347801
Pubmed

DNA topoisomerase II distribution in mouse preimplantation embryos.

TOP2A TOP2B

9.20e-062106211835579
Pubmed

Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues.

ROCK2 ROCK1

9.20e-062106222986902
Pubmed

Activation of Rho kinase isoforms in lung endothelial cells during inflammation.

ROCK2 ROCK1

9.20e-062106219201893
Pubmed

Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively.

ABCC1 TOP2A

9.20e-062106226617887
Pubmed

Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation.

ROCK2 ROCK1

9.20e-062106219997641
Pubmed

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.

TOP2A TOP2B

9.20e-06210622556712
Pubmed

Role of Rho kinase isoforms in murine allergic airway responses.

ROCK2 ROCK1

9.20e-062106221565918
Pubmed

The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders.

EEF1A1 EEF1A2

9.20e-062106230370994
Pubmed

Using a biochemical approach to identify the primary dimerization regions in human DNA topoisomerase IIalpha.

TOP2A TOP2B

9.20e-062106210473615
Pubmed

Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.

TOP2A TOP2B

9.20e-06210629224616
Pubmed

DNA damage response during chromatin remodeling in elongating spermatids of mice.

TOP2A TOP2B

9.20e-062106218032420
Pubmed

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.

TOP2A TOP2B

9.20e-062106222111588
Pubmed

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

TOP2A TOP2B

9.20e-062106217578914
Pubmed

The Rho kinase pathway regulates mouse adult neural precursor cell migration.

ROCK2 ROCK1

9.20e-062106221732490
Pubmed

Comparative Study of ROCK1 and ROCK2 in Hippocampal Spine Formation and Synaptic Function.

ROCK2 ROCK1

9.20e-062106230826947
Pubmed

Adjustable passive stiffness in mouse bladder: regulated by Rho kinase and elevated following partial bladder outlet obstruction.

ROCK2 ROCK1

9.20e-062106222205227
Pubmed

Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells.

ROCK2 ROCK1

9.20e-062106223479079
Pubmed

Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension.

ROCK2 ROCK1

9.20e-062106219590140
Pubmed

New insights on the interaction between the isoforms 1 and 2 of human translation elongation factor 1A.

EEF1A1 EEF1A2

9.20e-062106226212729
Pubmed

Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively.

TOP2A TOP2B

9.20e-06210621309226
Pubmed

Rho-GTPase effector ROCK phosphorylates cofilin in actin-meditated cytokinesis during mouse oocyte meiosis.

ROCK2 ROCK1

9.20e-062106224429217
Pubmed

Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module.

MLXIP MLXIPL

9.20e-062106216644671
Pubmed

Rocks: multifunctional kinases in cell behaviour.

ROCK2 ROCK1

9.20e-062106212778124
Pubmed

Rho kinases regulate corneal epithelial wound healing.

ROCK2 ROCK1

9.20e-062106218495812
Pubmed

ROCK1 but not ROCK2 contributes to RhoA signaling and NMIIA-mediated contractility at the epithelial zonula adherens.

ROCK2 ROCK1

9.20e-062106228035042
Pubmed

Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity.

ROCK2 ROCK1

9.20e-062106230196430
Pubmed

Role of Rho-kinase in regulation of insulin action and glucose homeostasis.

ROCK2 ROCK1

9.20e-062106216098829
Pubmed

Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth.

ROCK2 ROCK1

9.20e-062106228709411
Pubmed

Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonance.

TOP2A TOP2B

9.20e-062106214596941
Pubmed

Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.

TOP2A TOP2B

9.20e-062106217361331
Pubmed

The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade.

EEF1A1 EEF1A2

9.20e-062106217825975
Pubmed

Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression.

ROCK2 ROCK1

9.20e-062106221471517
InteractionKCTD13 interactions

ROCK2 RPL27 MYO6 PDHB RAPGEF4 HNRNPM DYRK1A POR LARP1 OAT ITGA2 HNRNPD MYEF2 EEF1A1 EEF1A2 CASK MLXIPL MICAL2 XRN1 MICAL3 EXOC1 TRAPPC9

2.39e-06139410522int:KCTD13
InteractionFER1L6 interactions

EEF1A1 EEF1A1P5 EEF1A2

4.74e-0671053int:FER1L6
InteractionH2BC12 interactions

LARP1 NEB HNRNPD EEF1A1 EEF1A1P5 EEF1A2 XRN1 ANKRD11 TOP2A TOP2B

7.11e-0632210510int:H2BC12
InteractionNR3C1 interactions

ABCC1 TBRG4 GOLGA6L2 MYO6 PDHB POLE POR IDE NEB HNRNPD MYEF2 EEF1A1P5 ACSL4 TXNDC5 BUD31 FGD5

4.29e-0597410516int:NR3C1
InteractionAHNAK interactions

RPL27 RAPH1 HNRNPM DYRK1A HNRNPD EEF1A1 SH3PXD2A ARL13B FGD5

4.32e-053181059int:AHNAK
InteractionPRKD2 interactions

DZIP1L EEF1A1 EEF1A1P5 EEF1A2 CASK TXNDC5 GLCE ACSBG2

5.55e-052541058int:PRKD2
InteractionH2BC4 interactions

LARP1 NEB HNRNPD EEF1A1P5 EEF1A2 XRN1 ANKRD11 TOP2B

6.36e-052591058int:H2BC4
InteractionTMOD2 interactions

ABCC1 MYO6 DYRK1A AVIL VAV1

6.92e-05821055int:TMOD2
InteractionTLN1 interactions

ROCK2 NRAP HNRNPM HNRNPD EEF1A1 EEF1A1P5 EEF1A2 ROCK1

7.27e-052641058int:TLN1
InteractionHTR5A interactions

HTR5A BUD31

8.04e-0531052int:HTR5A
InteractionADARB2 interactions

EEF1A1 EEF1A1P5 EEF1A2

8.86e-05171053int:ADARB2
Cytoband14q31

GALC ITPK1

1.88e-049106214q31
CytobandEnsembl 112 genes in cytogenetic band chr7q36

HTR5A NCAPG2 IQCA1L GALNT11

5.23e-041591064chr7q36
Cytoband7q36.1

HTR5A IQCA1L GALNT11

6.88e-047410637q36.1
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ROCK2 RASA1 RAPH1 PLEKHS1 IPCEF1 ROCK1 FGD5 VAV1

7.17e-07206658682
GeneFamilyTopoisomerases

TOP2A TOP2B

1.89e-0466521050
GeneFamilyClassical BAR domain containing

ARFIP2 ICA1L

3.51e-0486521292
GeneFamilyRNA binding motif containing

HNRNPM HNRNPD MYEF2 SCAF4 ALKBH8

1.01e-03213655725
GeneFamilyLIM domain containing

NRAP MICAL2 MICAL3

1.25e-03596531218
GeneFamilyPolypeptide N-acetylgalactosaminyltransferases

GALNT11 GALNT5

2.32e-0320652433
GeneFamilyAcyl-CoA synthetase family

ACSL4 ACSBG2

3.91e-032665240
GeneFamilySH2 domain containing

RASA1 FES VAV1

5.75e-03101653741
GeneFamilyCyclins|F-boxes other

FBXO10 FBXO21

8.66e-0339652560
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

ROCK2 ABCC1 RASA1 TRPC1 DYRK1A CASK ACSL4 PIK3C2A MICAL2 LTN1 ROCK1 MICAL3 SLC23A2 TOP2A

9.22e-0685610614M4500
CoexpressionCHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP

RASA1 ST6GAL1 HNRNPD MYEF2 CASK TOP2A

1.38e-051281066M8795
CoexpressionGSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP

RASA1 PDHB IRF4 OAT SGSM2 CBX1 MMP2

1.75e-052001067M3407
CoexpressionCHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP

RASA1 ST6GAL1 HNRNPD MYEF2 CASK TOP2A

1.95e-051361066MM464
CoexpressionFLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP

OAT BPHL MICAL2 IPCEF1 VAV1 TOP2B

3.92e-051541066M19681
CoexpressionHALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY

ABCC1 SCAF4 IPCEF1 FES

4.65e-05491064M5938
CoexpressionGSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP

KLHDC2 RAPGEF4 ST6GAL1 PIK3C2A SH3PXD2A TOP2B

7.03e-051711066M6316
CoexpressionGSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN

KLHDC2 RAPGEF4 ST6GAL1 PIK3C2A SH3PXD2A TOP2B

7.03e-051711066M6321
CoexpressionGRYDER_PAX3FOXO1_TOP_ENHANCERS

RAPH1 PDHB POR OAT NCAPG2 GALNT11 XRN1 FBXO21 TOP2A

7.75e-054411069M172
CoexpressionGSE14699_NAIVE_VS_ACT_CD8_TCELL_DN

KLHDC2 RAPGEF4 ST6GAL1 PIK3C2A SH3PXD2A IPCEF1

7.98e-051751066M2940
CoexpressionGSE3565_DUSP1_VS_WT_SPLENOCYTES_DN

KLHDC2 RAPGEF4 ST6GAL1 PIK3C2A SH3PXD2A TOP2B

9.04e-051791066M6324
CoexpressionWANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP

NCAPG2 EEF1A2 UCKL1

9.36e-05221063M2082
CoexpressionGSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP

POLE NEB NCAPG2 LY75 SLC23A2 TOP2A

1.02e-041831066M2993
CoexpressionNAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP

GALC IRF4 ST6GAL1 MLXIP TLR8 PIK3C2A MICAL2 TGFBRAP1 IPCEF1

1.40e-044771069M40930
CoexpressionGSE28408_LY6G_POS_VS_NEG_DC_UP

CASK IRF9 SGSM2 PGAP1 ANKRD11 LY75

1.53e-041971066M9547
CoexpressionGSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP

RAPH1 KLHDC2 IRF4 NEB MYEF2 MGAT5B

1.57e-041981066M7200
CoexpressionGSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN

IRF4 OAT ARFIP2 ATP8B2 NLRP6 TXNDC5

1.66e-042001066M9482
CoexpressionGSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN

RAPH1 ATP8B2 ITPK1 TXNDC5 TGFBRAP1 CBX1

1.66e-042001066M4889
CoexpressionGSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN

KLHDC2 HNRNPD MYEF2 SMG7 LTN1 BUD31

1.66e-042001066M4979
CoexpressionGSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP

KLHDC2 PDHB IDE TXNDC5 TOP2A TOP2B

1.66e-042001066M6950
CoexpressionTBK1.DF_DN

ROCK2 MYO6 IDE ITGA2 BPHL GALNT11 ANKRD11

1.66e-042861067M2864
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPH1 MYO6 NEXMIF ST6GAL1 ITGA2 ITPK1 CAPN8

4.23e-0719410674579b4a44f7c731553a284843c296866027d7c0e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPH1 MYO6 NEXMIF ST6GAL1 ITGA2 ITPK1 CAPN8

4.85e-0719810670d9d401190792fd61434f1b82548253187d805f0
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass

NEB CAPN8 ALKBH8 BPHL GALNT11 LTN1

3.21e-061691066dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

BCL2L14 MYO6 ST6GAL1 ITGA2 CAPN8 MICAL2

4.77e-061811066576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 ABCA9 TLR8 PGAP1 XRN1 TOP2B

4.92e-061821066f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO6 ITGA2 IPCEF1 XRN1 LY75 TOP2B

4.92e-061821066e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO6 ITGA2 IPCEF1 XRN1 LY75 TOP2B

4.92e-0618210661710eab3037a87609d21838be2d2d29c3bc36651
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 ABCA9 TLR8 XRN1 CBX1 TOP2B

5.41e-0618510667adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell(04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint

GALC DZIP1L IRF4 MYEF2 BPHL TOP2A

5.93e-061881066f911dc61b008b60aaa2a1e9354085f480a669e2c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ROCK2 RAPH1 MYO6 NEXMIF ITGA2 SLC23A2

6.69e-0619210662510f22197502f60fd266b7f42eff040f25b8ae7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ROCK2 RAPH1 MYO6 NEXMIF ITGA2 SLC23A2

6.69e-061921066e8e316f396834bcd34843e56e1d86f310fd6aada
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 NEB ABCA9 EEF1A2 XRN1 MMP2

7.30e-0619510665c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPH1 MYO6 NEXMIF ST6GAL1 ITGA2 CAPN8

7.30e-0619510663d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

BCL2L14 ITGA2 ACSL4 ACSBG2 GALNT5

1.34e-0512710655b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RAPH1 PLEKHS1 TLR8 LTN1 MICAL3

3.82e-05158106574aa4f75307575ac3b2b1aa9f727753692f88742
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF4 NAPG SH3PXD2A FES MGAT5B

4.05e-051601065830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCellileum|World / shred on tissue and cell subclass

ROCK2 MLXIPL TREH SLC23A2 ZG16

5.41e-0517010659f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCellfacs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF4 NEB MLXIPL TXNDC5 AVIL

5.71e-05172106565b8935a972bf00b7a10dc2d442128fc0ed78bcb
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF4 ST6GAL1 IRF9 FGD5 MGAT5B

5.87e-051731065afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 ABCA9 TLR8 XRN1 TOP2B

6.37e-051761065749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellBAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 RAPGEF4 ITGA2 CAPN8 GALNT5

6.72e-0517810659a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCellBAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 RAPGEF4 ITGA2 CAPN8 GALNT5

6.72e-051781065b413a634283550fa224db7d0d05956e3f64694a1
ToppCellBAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 RAPGEF4 ITGA2 CAPN8 GALNT5

6.72e-05178106549a2271718637522f74334068d252963ee13b1ce
ToppCellBAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYO6 RAPGEF4 ITGA2 CAPN8 GALNT5

6.72e-05178106519b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLEKHS1 CAPN8 SH3PXD2A SGSM2 IPCEF1

6.90e-0517910656e965e424eebef50f0202cff75f458be395cfca1
ToppCellfacs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPL27 POLE NLRP6 MLXIPL TOP2A

7.27e-0518110659fce5eee75684a7ecac6996e26e9215bc95098b2
ToppCellfacs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPL27 POLE NLRP6 MLXIPL TOP2A

7.27e-051811065ad97e802e934738ddece675232a72308db2da256
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NOL4 MLXIPL TREH ACSBG2 ZG16

7.66e-051831065d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ST6GAL1 TXNDC5 SH3PXD2A GALNT5 ZG16

7.66e-0518310655a936fb07074cec753bf19e3e3e52499605ea22c
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ST6GAL1 TXNDC5 SH3PXD2A GALNT5 ZG16

7.66e-05183106507c18ccc45ddc9c22e482bd9ffb87f46ebcfe473
ToppCell3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLEKHS1 OAT ST6GAL1 CAPN8 ZG16

7.86e-051841065c2ca984551baf4becbefbe58bd1889828542b045
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 XRN1 ANKRD11 CBX1 TOP2B

7.86e-0518410651154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYO6 ITGA2 CAPN8 ACSL4 MICAL2

8.27e-051861065acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

ROCK2 IDE PIK3C2A TGFBRAP1 LTN1

8.27e-05186106503db813598b67b1e08f759758a1c2023396921fa
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MYO6 ITGA2 ABCA9 CAPN8 ACSL4

8.48e-05187106577886f99c229610abd28c4c370d2c7d1536c9782
ToppCellT_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

BCL2L14 IFIT5 IPCEF1 PGAP1 XRN1

8.70e-0518810656f8946d4710f6e32c937213f99b790b098b8819c
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

BCL2L14 ITGA2 ACSL4 MICAL2 GALNT5

8.70e-0518810654bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq

NAPG NCAPG2 MICAL2 GLCE MMP2

8.92e-051891065316c857dec9383823e09f966bca62d52d933b141
ToppCellSevere_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

MYO6 ITGA2 MYEF2 CAPN8 GALNT5

8.92e-0518910658cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CASK ACSL4 IPCEF1 MICAL3 MGAT5B

8.92e-0518910658c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CASK ACSL4 IPCEF1 MICAL3 MGAT5B

8.92e-0518910655d902a4660a27548764bf04c6de152b565da835c
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

POLE LARP1 NCAPG2 SPATA1 TRAPPC9

9.60e-051921065930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

POLE LARP1 NCAPG2 SPATA1 TRAPPC9

9.60e-051921065c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DZIP1L ST6GAL1 ITGA2 TXNDC5 GALNT5

9.84e-0519310656a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MYO6 RAPGEF4 PHEX IPCEF1 MMP2

9.84e-0519310655e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RAET1E ABCA9 EEF1A2 ACSBG2 MGAT5B

9.84e-051931065e5016959f24370579a8770787e96869f264cf7b3
ToppCellnormal_Pleural_Fluid-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

BCL2L14 IRF4 EEF1A1 SH3PXD2A LY75

1.01e-04194106530f683725cb13ae32ef6846618801ec78e12397d
ToppCelltumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

BCL2L14 IRF4 EEF1A1 SH3PXD2A LY75

1.03e-04195106572a7c4beb880390b29f3c5d6dd9dbb082af50fe2
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO6 RAPGEF4 MLXIPL XRN1 ANKRD11

1.03e-0419510657796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellMild-CD4+_T_activated|World / Disease group and Cell class

BCL2L14 IFIT5 IPCEF1 PGAP1 XRN1

1.06e-041961065417b4fc2e4388f34c410576131b02936f93e46b6
ToppCellAT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

MYO6 ST6GAL1 ITGA2 CASK MICAL2

1.08e-0419710655e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO6 OAT MLXIP MLXIPL PGAP1

1.11e-041981065a4543d636501a1b5b46c14a661ce9d169947c82c
ToppCellImmune_cells-large_pre-B.|Immune_cells / Lineage and Cell class

POLE NCAPG2 HNRNPD CBX1 TOP2A

1.11e-041981065bc9ceefadb153907d2854d1f736d17349003cb31
ToppCell3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO6 ITGA2 MLXIP MLXIPL PGAP1

1.11e-041981065e8bfae3888b2406b5629b576cb02913b3297337e
ToppCell5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLEKHS1 OAT MLXIP MLXIPL PGAP1

1.14e-041991065f544229f471b4717166dd4b588399afe45cc31b5
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

ROCK2 MYO6 NAPG ANKRD11 ROCK1

1.14e-04199106553ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

MYO6 NAPG HNRNPD ANKRD11 ROCK1

1.14e-041991065fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellTransverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass

RAPH1 DZIP1L ABCA9 TLR8 MLXIPL

1.14e-041991065facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCellVE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster

BCL2L14 IFIT5 IRF9 PGAP1 XRN1

1.14e-041991065056a0538ca5e825ae6195b4c76c208708a014533
ToppCellTransverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype

RAPH1 DZIP1L ABCA9 TLR8 MLXIPL

1.14e-041991065dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCell5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO6 PLEKHS1 OAT HNRNPD MLXIPL

1.16e-042001065742441800a2d167c19cee4816ff77424ae6675c6
Druglevormeloxifene

ROCK2 ROCK1 MMP2

1.89e-0661053ctd:C108255
DrugMenadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

TRPC1 IFIT5 SCAF4 SMG7 TGFBRAP1 GLCE ROCK1 SLC23A2

3.31e-0619410584662_DN
DrugDexrazoxane

TOP2A TOP2B

2.11e-0521052DB00380
DrugRockout

ROCK2 ROCK1

2.11e-0521052CID000644354
Drug3,3-dimethylacryloyl chloride

ROCK2 ROCK1

2.11e-0521052CID000102394
Drugbis(4-amino-3-methylcyclohexyl)methane

PIK3C2A GLCE

2.11e-0521052CID000091555
DrugF14512

TOP2A TOP2B

2.11e-0521052ctd:C534191
DrugDaunorubicin

TOP2A TOP2B

2.11e-0521052DB00694
Drug8-methoxycaffeine

PIK3C2A TOP2B

2.11e-0521052CID000011286
Drug8-chlorocaffeine

PIK3C2A TOP2B

2.11e-0521052CID000021031
Drug2-MeSAMP

ROCK2 ROCK1 MMP2

2.64e-05131053CID000189762
DrugB-43

ROCK2 ROCK1 VAV1

3.34e-05141053CID006603792
DrugMefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A

ROCK2 TRPC1 SCAF4 CASK PGAP1 MMP2 SLC23A2

3.52e-0519610571821_UP
DrugCefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A

TBRG4 ATP8B2 HNRNPD SCAF4 IRF9 TGFBRAP1 GLCE

3.87e-0519910577148_DN
Diseasedevelopmental and epileptic encephalopathy 33 (implicated_via_orthology)

EEF1A1 EEF1A1P5 EEF1A2

4.13e-0831033DOID:0080463 (implicated_via_orthology)
DiseaseB cell deficiency (implicated_via_orthology)

TOP2A TOP2B

1.21e-0521032DOID:2115 (implicated_via_orthology)
DiseaseNeurodevelopmental Disorders

NEXMIF DYRK1A EEF1A2 CASK ANKRD11

1.91e-05931035C1535926
DiseaseR-6-hydroxywarfarin measurement

ABCC1 NAPG OAT GLCE TRAPPC9

5.10e-051141035EFO_0803327
DiseaseEpilepsy, Cryptogenic

NEXMIF DYRK1A EEF1A2 ANKRD11

1.99e-04821034C0086237
DiseaseAwakening Epilepsy

NEXMIF DYRK1A EEF1A2 ANKRD11

1.99e-04821034C0751111
DiseaseAura

NEXMIF DYRK1A EEF1A2 ANKRD11

1.99e-04821034C0236018
Diseaseretinal vein occlusion (is_implicated_in)

ITGA2 MMP2

2.51e-0471032DOID:1727 (is_implicated_in)
DiseaseX-17676 measurement

DNAH3 BPHL

3.33e-0481032EFO_0800785
Diseasemean reticulocyte volume

ABCC1 RAPH1 NEXMIF DYRK1A MLXIP NEB SERPINA2 MLXIPL LY75 TRAPPC9

4.90e-0479910310EFO_0010701
Diseasecoffee consumption measurement, tea consumption measurement

POR XRN1 CBX1

4.93e-04441033EFO_0006781, EFO_0010091
DiseaseEpilepsy

NEXMIF DYRK1A EEF1A2 ANKRD11

5.88e-041091034C0014544
Diseasefetal genotype effect measurement, body weights and measures

SERPINA2 FES FGD5

6.77e-04491033EFO_0004324, EFO_0007959
Diseaseretinal drusen

ITGA2 CAPN8 SLC23A2

7.62e-04511033EFO_1001155
Diseaseacute myeloid leukemia (implicated_via_orthology)

TOP2A TOP2B

7.78e-04121032DOID:9119 (implicated_via_orthology)
Diseasemean platelet volume

PDHB DYRK1A ITGA2 EEF1A1P5 NLRP6 ACSL4 MLXIPL ANKRD11 LY75 ICA1L VAV1

8.77e-04102010311EFO_0004584
DiseaseMetabolic Bone Disorder

ANKRD11 MMP2

1.07e-03141032C0005944
Diseasebasophil measurement

ABCC1 DYRK1A EEF1A1P5

1.22e-03601033EFO_0803539
Diseasequinate measurement

GRID1 ITGA2

1.23e-03151032EFO_0021167
DiseaseOsteopenia

ANKRD11 MMP2

1.23e-03151032C0029453
Diseasehepcidin:transferrin saturation ratio

PDHB NLRP6

1.23e-03151032EFO_0007902
Diseaseendometriosis (biomarker_via_orthology)

MMP2 VAV1

1.40e-03161032DOID:289 (biomarker_via_orthology)
Diseasecoffee consumption, cups of coffee per day measurement

POR MLXIPL

1.40e-03161032EFO_0004330, EFO_0006782
Diseasephosphorus measurement

BCL2L14 PHEX

1.40e-03161032EFO_0004861
Diseaseskin sensitivity to sun

IRF4 ANKRD11

1.99e-03191032EFO_0004795
Diseaseautism spectrum disorder (implicated_via_orthology)

NEXMIF TRPC1 DYRK1A CASK

2.02e-031521034DOID:0060041 (implicated_via_orthology)
DiseaseMammary Neoplasms, Experimental

RASA1 EEF1A1 CASK MMP2

2.16e-031551034C0024668
Diseaseautism spectrum disorder

RAET1E SERPINA2 SGSM2 MGAT5B

2.21e-031561034EFO_0003756
Diseaseprostate cancer (is_marker_for)

MYO6 CBX1 MMP2 TOP2A

2.21e-031561034DOID:10283 (is_marker_for)
Diseaseintellectual disability (implicated_via_orthology)

DYRK1A CAPN8 TRAPPC9

2.32e-03751033DOID:1059 (implicated_via_orthology)
Diseasefat intake measurement

NRAP MLXIPL

2.66e-03221032EFO_0010809
Diseasedilated cardiomyopathy (implicated_via_orthology)

EEF1A1 EEF1A1P5 EEF1A2

2.79e-03801033DOID:12930 (implicated_via_orthology)
DiseaseColorectal Neoplasms

ABCC1 POLE GRID1 ABCA9 MMP2

2.91e-032771035C0009404
Diseaseresponse to antiviral drug, cirrhosis of liver

EEF1A2 MLXIPL

3.17e-03241032EFO_0001422, EFO_0010123
DiseaseColorectal Carcinoma

ABCC1 DNAH3 HTR5A POLE GRID1 ABCA9 ACSL4 MMP2

3.23e-037021038C0009402
Diseasealanine measurement

MCPH1 MLXIP SCAF4

3.43e-03861033EFO_0009765

Protein segments in the cluster

PeptideGeneStartEntry
LKKKAFVWARNIGFK

ACSBG2

341

Q5FVE4
NGKVFKKLILGNYKW

ACSL4

111

O60488
KSYDGWLDFKKLIQV

ACSM6

191

Q6P461
EGYADKNLIAKWKKQ

BUD31

81

P41223
KIYVWKGKGATKAEK

AVIL

291

O75366
KKGKEKSWYIADIFT

ANKRD11

1106

Q6UB99
SFLEKWLRKGYIKHK

ALKBH8

206

Q96BT7
LFLKKKWGIGYHLSL

ABCA9

701

Q8IUA7
KNWAYKYLLGLIKSS

FBXO10

266

Q9UK96
LGKKKSSWKAFFGVV

BCL2L14

86

Q9BZR8
FVKRWKSYLKGSRAK

GLCE

601

O94923
EKFDIVKKWGINTYK

ARFIP2

91

P53365
YGKKIDKSIKKGLYW

ARL13B

171

Q3SXY8
GAVEFKTLWLKIQKY

CAPN8

596

A6NHC0
GTWNLKKTKDGKREY

DYRK1A

401

Q13627
KLDKFSGTLYWKENK

ATP8B2

226

P98198
KNKKTYIFAGDKFWR

MMP2

576

P08253
WKKDRGLEKYFRKLS

RAET1E

171

Q8TD07
KDDGKKSWKKRYFLL

RAPH1

406

Q70E73
LLKKGKGKRWKNLYF

RASA1

481

P20936
FKSLLSQNKFWKYGK

LTN1

251

O94822
TKLYGEIDKLKKLFW

DZIP1L

261

Q8IYY4
GRKALTWKYYAKKIL

FBXO21

156

O94952
AYKVSRGLWKKYGDK

PDHB

66

P11177
ASCTWFGKKKKQYKD

CASK

696

O14936
EKFWAFLKYSKAKNL

LARP1

991

Q6PKG0
WAKLDKRGSHKDYKK

MICAL3

66

Q7RTP6
GYWLSEKKIKKLNFQ

ITPK1

11

Q13572
SGKKKATVKYLSEKW

MCPH1

801

Q8NEM0
GLLTYWFLFRKKKEE

POR

36

P16435
EDAALFKAWALFKGK

IRF4

66

Q15306
LFSEVKYKEGWEKTK

NRAP

541

Q86VF7
VFVANLDYKVGWKKL

HNRNPM

206

P52272
LDYKVGWKKLKEVFS

HNRNPM

211

P52272
YGKEASIWKLQGKEK

MGAT5B

466

Q3V5L5
GLSKEDKAFLWEKRY

PIK3C2A

886

O00443
KKLWFVIKGKVLYTY

FGD5

1381

Q6ZNL6
RKKLGCKSFKWYLDN

GALNT11

436

Q8NCW6
KKYDKSLRKYFWTGL

LY75

546

O60449
KLAEAKKKFTDYRQW

GOLGA6L2

21

Q8N9W4
YEFKGLHKVWKKKLS

POLE

766

Q07864
AILWKLGFFKRKYEK

ITGA2

1151

P17301
AYSGKLVSPKWKNFK

MLXIP

136

Q9HAP2
VDYISFHGKWKDKFK

SERPINA2

211

P20848
GWLYKKKEKGSFLSN

IPCEF1

46

Q8WWN9
WALLKFGGKYYQKAK

IFIT5

146

Q13325
YWGVSKKILGDLKFL

DNAH3

2826

Q8TD57
KLKCKSFKWYLENVF

GALNT5

786

Q7Z7M9
KGSFKYAWVLDKLKA

EEF1A2

51

Q05639
KGSFKYAWVLDKLKA

EEF1A1

51

P68104
VVKGKVEYLLKWKGF

CBX1

31

P83916
WKIYKAAKFRVGSRK

HTR5A

221

P47898
KGSFKYAWVLDKLKA

EEF1A1P5

51

Q5VTE0
AAFFKAWAIFKGKYK

IRF9

56

Q00978
KAKKGNYAFLWDVAV

GRID1

731

Q9ULK0
DKLGVWVYKNKLIFF

KLHDC2

146

Q9Y2U9
KKSDKGDFYKRQIAW

EXOC1

56

Q9NV70
KPKKLSAECAKYWGE

IDE

896

P14735
KKYWKTKQVFIKATG

ICA1L

21

Q8NDH6
KALKFKKVSLLGWSD

BPHL

126

Q86WA6
WYTKLGKTSERFLFK

GALC

426

P54803
VKFEERYKTGKNKWF

RPL27

116

P61353
KIAWALNKGIKADYK

SCAF4

576

O95104
AAKKILYDWAAGKLY

NLRP6

211

P59044
ELKSEWQKGAYLKDK

TBRG4

606

Q969Z0
KAKALWYKLDKRGSH

MICAL2

61

O94851
DVKGALKKVLWKNYD

OR2B8P

296

P59922
GIKVLKLYAWELAFK

ABCC1

511

P33527
KLYAWELAFKDKVLA

ABCC1

516

P33527
DKAKDKYVRSLWKLF

FES

166

P07332
WDTTKKDLKDYFSKF

HNRNPD

106

Q14103
TWEKLPSKFKKFYAE

RAPGEF4

881

Q8WZA2
QKAWKIKYYKGLGTS

TOP2B

626

Q02880
FVANLDFKVGWKKLK

MYEF2

236

Q9P2K5
SLKDWYFKTPLGKKS

IQCA1L

781

A6NCM1
NKYAKLAPLKGFWQK

NEXMIF

576

Q5QGS0
KTKWGVSDFIKAFIK

SMG7

241

Q92540
AGLTKDVWSKYQKDK

SGSM2

536

O43147
YLSEKLKLKDKWLGV

SHCBP1L

146

Q9BZQ2
WKEKKKGSYYDSFKL

ST6GAL1

26

P15907
IKFLLGYKWFKELWD

PGAP1

646

Q75T13
AYSGKLVSPKWKNFK

MLXIPL

96

Q9NP71
AKFKFWVKSKGFQLG

NOL4

51

O94818
KLARKWGYTVKGIQK

OAT

151

P04181
WGYTVKGIQKYKAKI

OAT

156

P04181
GWKKKYLETKKVTAS

SPATA1

341

Q5VX52
YFRAWKKASGKILEA

NCAPG2

266

Q86XI2
CQGWLYKKKEKGSFL

CNK3/IPCEF1

506

G9CGD6
YKKKEKGSFLSNKWK

CNK3/IPCEF1

511

G9CGD6
RKKDLKDSFLWRYGK

PRY

51

O14603
KFARAKLWLSYFDDK

TRPC1

661

P48995
WKKRFFILSKAGEKS

PLEKHS1

36

Q5SXH7
LTKKYAKSWNFKTAF

TLR8

946

Q9NR97
AWLEKHKKYFALGLL

TGFBRAP1

481

Q8WUH2
RGKAFKWFSTLIKHK

ZNF99

206

A8MXY4
IYKSKKGWTAYKLQL

SLC23A2

296

Q9UGH3
AEKYLKTGFLKWKPD

NAPG

16

Q99747
KEGWAPASYLKKAKD

SH3PXD2A

311

Q5TCZ1
GYELFFKTRELKKKW

VAV1

481

P15498
TGAWFDYDLEKKKKN

TREH

396

O43280
VDLKWFESKVGNKYL

XRN1

356

Q8IZH2
YWKKAGLNVKGKRTL

PHEX

626

P78562
KKFGWVKKYVIVSSK

ROCK2

1166

O75116
YGWKKQYVVVSSKKI

ROCK1

1136

Q13464
YKWYLKKLVFVTDKG

ZG16

101

O60844
KEKGDWTKLGKLYIN

TOPAZ1

1291

Q8N9V7
KKWKVKYYKGLGTST

TOP2A

606

P11388
KKDWKTLYGANVIIF

UCKL1

191

Q9NWZ5
LWFRDGKKVDQYKGK

TXNDC5

266

Q8NBS9
LTTKEKLYGDFLSWK

TRAPPC9

756

Q96Q05
KAAAGTKKYDLSKWK

MYO6

1076

Q9UM54
KADWKKTIAKGYDLR

NEB

1541

P20929